As pharma companies forge ahead, the need for agility and adaptability in change management becomes crucial for sustained growth. This discussion will explore the new structures and strategies necessary to thrive in

• Transforming marketing frameworks within the pharmaceutical industry, focusing on the shift from traditional linear processes to more collaborative, cross-stakeholder models
• Embracing agile structures and strategies that allow for quick adaptation to changes in the market and organizational landscape
• Redefining decision-making roles and understanding the new leadership structure and how decisions will be made